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Tuberculosis affects much of the world population and each year, it is estimated that 9.2 million new 
cases appear, of which many lead to death.1 The emergence of multidrug resistant tuberculosis (MDR-
TB) and extensively drug resistant tuberculosis (XDR-TB) caused urgency in the search for new 
antitubercular agents.2  
 
Recently in our research group the pyrimido[5,4-d]pyrimidines 4 were identified as a promising new 
class of antitubercular agents3 and a research program is under development in order to generate new 
derivatives 3 for SAR studies. Compounds 4 were obtained efficiently from the reaction of 6-
cyanopurines 1 with hydrazides and were considered convenient precursors to generate the new target 
compounds 3 by Dimroth rearrangement. 
 
When the rearrangement of compounds 4 was induced by acid or base treatment, compounds 3 were 
identified by 1H NMR as major components in the reaction mixtures but could not be separated as pure 
products. In order to generate the target compounds 3 a new synthetic approach was designed from 
purines 2. Compounds 2 may be obtained from 1 under rigorously controlled experimental conditions. A 
discussion of the reaction conditions to generate amidines 2, the target compounds 3 and the mechanistic 
studies to generate 3 from 2 will be presented. 
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